157 related articles for article (PubMed ID: 37091143)
1. The prognostic value of postoperative radiotherapy in right tumor for lung related death: based on SEER database and real-world data.
Mo Y; Chen M; Wang M; Wu M; Yu J
Front Oncol; 2023; 13():1178064. PubMed ID: 37091143
[TBL] [Abstract][Full Text] [Related]
2. The high-risk features and effect of postoperative radiotherapy on survival for patients with surgically treated stage IIIA-N2 non-small cell lung cancer.
Zhu M; Li S; Yuan L; Liu S; Li J; Zhang D; Chen J; Jiang J; Xu Z
World J Surg Oncol; 2023 Aug; 21(1):238. PubMed ID: 37537652
[TBL] [Abstract][Full Text] [Related]
3. Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER database.
Wang X; Song J; Long J; Zeng Z; Liu A
Radiat Oncol; 2021 Sep; 16(1):184. PubMed ID: 34544464
[TBL] [Abstract][Full Text] [Related]
4. Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER database.
Yang R; Gong J; Liao Z; Yu J; Zhang J; Xie C
Transl Cancer Res; 2022 Jul; 11(7):2194-2204. PubMed ID: 35966291
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
[TBL] [Abstract][Full Text] [Related]
6. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Xie M; Tian J; Song X; Wu B; Liu L
Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients.
Gao F; Li N; Xu Y; Yang G
Front Oncol; 2020; 10():1135. PubMed ID: 32850322
[No Abstract] [Full Text] [Related]
8. Effects of Postoperative Radiotherapy on Survival of Patients With Stage IIIA Resected Non-Small Cell Lung Cancer: Analysis of the SEER Database.
Gao F; Li N; Xu Y; Yang G
J Natl Compr Canc Netw; 2020 Jun; 18(6):718-727. PubMed ID: 32502986
[TBL] [Abstract][Full Text] [Related]
9. Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Sun X; Men Y; Wang J; Bao Y; Yang X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2021 May; 12(9):1358-1365. PubMed ID: 33728811
[TBL] [Abstract][Full Text] [Related]
10. Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA-N2 resected non-small cell lung cancer.
Jin X; Chen D; Shen Y; Shu J; Sang Y; Yang W; Duan S; Chen Y
Thorac Cancer; 2022 Oct; 13(19):2767-2775. PubMed ID: 36054738
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
13. The impact of postoperative radiotherapy on the survival of patients with stage III non-small cell lung cancer: A CONSORT-compliant analysis using the SEER database.
Wu K; Peng W; Shuai Z; Peng X; Liu H; Zhang S
Medicine (Baltimore); 2023 Jun; 102(24):e34015. PubMed ID: 37327271
[TBL] [Abstract][Full Text] [Related]
14. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database.
Chen D; Yu J
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833420
[No Abstract] [Full Text] [Related]
16. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
[TBL] [Abstract][Full Text] [Related]
17. Male patients with resected IIIA-N2 non-small-cell lung cancer may benefit from postoperative radiotherapy: a population-based survival analysis.
Kou P; Wang H; Lin J; Zhang Y; Yu J
Future Oncol; 2018 Oct; 14(23):2371-2381. PubMed ID: 29807451
[TBL] [Abstract][Full Text] [Related]
18. Mediastinal radiotherapy after adjuvant chemotherapy for resected non-small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis.
Harling L; Jayakumar S; Ashrafian H; Bille A; Toufektzian L; Smith D
JTCVS Open; 2021 Mar; 5():121-130. PubMed ID: 36003173
[TBL] [Abstract][Full Text] [Related]
19. The impact of order with radiation therapy in stage IIIA pathologic N2 NSCLC patients: a population-based study.
Duan H; Liang L; Xie S; Wang C
BMC Cancer; 2020 Aug; 20(1):809. PubMed ID: 32847544
[TBL] [Abstract][Full Text] [Related]
20. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
Herskovic A; Mauer E; Christos P; Nagar H
J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
